Back to Search
Start Over
Prognostic significance of remotely monitored nocturnal heart rate in heart failure patients with reduced ejection fraction.
- Source :
-
Heart rhythm [Heart Rhythm] 2023 Feb; Vol. 20 (2), pp. 233-240. Date of Electronic Publication: 2022 Oct 28. - Publication Year :
- 2023
-
Abstract
- Background: Elevated resting heart rate is a risk factor for cardiovascular events.<br />Objective: The purpose of this study was to investigate the clinical significance of nocturnal heart rate (nHR) and 24-hour mean heart rate (24h-HR) obtained by continuous remote monitoring (RM) of implantable devices.<br />Methods: We analyzed daily-sampled trends of nHR, 24h-HR, and physical activity in patients on β-blocker therapy for chronic heart failure and with implantable cardioverter-defibrillators or cardiac resynchronization therapy defibrillators (CRT-Ds). Patients were grouped by average nHR and 24h-HR quartile during follow-up to estimate the respective incidence of nonarrhythmic death and device-treated ventricular tachycardia/fibrillation (VT/VF).<br />Results: The study cohort included 1330 patients (median age 69 years [interquartile range 61-77 years]; 41% [n = 550] with CRT-D; median follow-up 25 months [interquartile range 13-42 months]). Compared with patients in the lowest nHR quartile (≤57 beats/min) group, patients in the highest quartile group (>65 beats/min) had an increased risk of nonarrhythmic death (adjusted hazard ratio [AHR] 2.25; 95% confidence interval [CI] 1.13-4.50; P = .021) and VT/VF (AHR 1.98; 95% CI 1.40-2.79; P < .001) and were characterized by the lowest level of physical activity (P ≤ .0004 vs every other nHR quartiles). The highest 24h-HR quartile group (>75 beats/min) showed an increased risk of VT/VF (AHR 2.13; 95% CI 1.52-2.99; P < .001) and a weaker though significant association with nonarrhythmic mortality (AHR 1.80; 95% CI 1.00-3.22; P = .05) as compared with the lowest 24h-HR quartile group (≤65 beats/min).<br />Conclusion: In remotely monitored patients with implantable cardioverter-defibrillator/CRT-D on β-blocker therapy for heart failure, elevated heart rates (nHR >65 beats/min and 24h-HR >75 beats/min) were associated with increased mortality and VT/VF risk. nHR showed a stronger association than 24h-HR with worst prognosis and lowest physical activity.<br /> (Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Middle Aged
Aged
Heart Rate
Prognosis
Stroke Volume
Ventricular Fibrillation therapy
Arrhythmias, Cardiac therapy
Risk Factors
Tachycardia, Ventricular etiology
Tachycardia, Ventricular therapy
Heart Failure complications
Heart Failure diagnosis
Heart Failure therapy
Cardiac Resynchronization Therapy adverse effects
Defibrillators, Implantable adverse effects
Ventricular Dysfunction, Left complications
Subjects
Details
- Language :
- English
- ISSN :
- 1556-3871
- Volume :
- 20
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Heart rhythm
- Publication Type :
- Academic Journal
- Accession number :
- 37283031
- Full Text :
- https://doi.org/10.1016/j.hrthm.2022.10.018